Literature DB >> 11989993

Early detection of isolated memory deficits in the elderly: the need for more sensitive neuropsychological tests.

C A de Jager1, E Milwain, M Budge.   

Abstract

BACKGROUND: Early detection of cognitive decline in the elderly is important because this may precede progression to Alzheimer's disease. The aim of this study was to see whether sensitive neuropsychological tests could identify pre-clinical cognitive deficits and to characterize the cognitive profile of a subgroup with poor memory.
METHODS: A neuropsychological test battery was administered to a community-dwelling sample of 155 elderly volunteers who were screened with CAMCOG at enrolment (mean age 74.7 years). The battery included tests of episodic memory. semantic and working memory, language and processing speed.
RESULTS: Episodic memory test z scores below 1 S.D. from the cohort mean identified 25 subjects with non-robust' memory performance. This group was compared to the remaining 'robust memory' group with a General Linear Model controlling for age, IQ, education and gender. Test performance was significantly different in all tests for episodic and semantic memory, but not in tests for working memory, processing speed and language. CANTAB paired associates learning and spatial recognition tests identified the highest percentages of those in the 'non-robust memory group. Processing speed partialled out the age effect on memory performance for the whole cohort, but the 'non-robust memory' group's performance was not associated with age or processing speed.
CONCLUSIONS: Sensitive neuropsychological tests can detect performance below the norm in elderly people whose performance on MMSE and CAMCOG tests is well within the normal range. Age-related decline in memory performance in a cohort of the elderly may be largely due to inclusion within the cohort of individuals with undetected pre-clinical Alzheimer's disease or isolated memory impairment.

Entities:  

Mesh:

Year:  2002        PMID: 11989993     DOI: 10.1017/s003329170200524x

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  27 in total

1.  Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

Authors:  Alexander P Lin; Frederick Shic; Cathleen Enriquez; Brian D Ross
Journal:  MAGMA       Date:  2003-02       Impact factor: 2.310

2.  Face-name associative memory performance is related to amyloid burden in normal elderly.

Authors:  Dorene M Rentz; Rebecca E Amariglio; J Alex Becker; Meghan Frey; Lauren E Olson; Katherine Frishe; Jeremy Carmasin; Jacqueline E Maye; Keith A Johnson; Reisa A Sperling
Journal:  Neuropsychologia       Date:  2011-06-12       Impact factor: 3.139

3.  Environmental heat exposure and cognitive performance in older adults: a controlled trial.

Authors:  Beatriz Maria Trezza; Daniel Apolinario; Rafaela Sanchez de Oliveira; Alexandre Leopold Busse; Fábio Luiz Teixeira Gonçalves; Paulo Hilário Nascimento Saldiva; Wilson Jacob-Filho
Journal:  Age (Dordr)       Date:  2015-04-28

4.  Computerized Cognitive Tests Are Associated with Biomarkers of Alzheimer's Disease in Cognitively Normal Individuals 10 Years Prior.

Authors:  Anja Soldan; Corinne Pettigrew; Abhay Moghekar; Marilyn Albert
Journal:  J Int Neuropsychol Soc       Date:  2016-11       Impact factor: 2.892

5.  A longitudinal study of cognitive trajectories in Mexican Americans age 75 and older.

Authors:  Brian Downer; Nai-Wei Chen; Mukaila Raji; Kyriakos S Markides
Journal:  Int J Geriatr Psychiatry       Date:  2016-09-06       Impact factor: 3.485

Review 6.  Disentangling the genetic determinants of human aging: biological age as an alternative to the use of survival measures.

Authors:  David Karasik; Serkalem Demissie; L Adrienne Cupples; Douglas P Kiel
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2005-05       Impact factor: 6.053

7.  Advances in designs for Alzheimer's disease clinical trials.

Authors:  Jeffrey Cummings; Heath Gould; Kate Zhong
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

8.  Development of a psychometrically equivalent short form of the Face-Name Associative Memory Exam for use along the early Alzheimer's disease trajectory.

Authors:  Kathryn V Papp; Rebecca E Amariglio; Maria Dekhtyar; Kamolika Roy; Sarah Wigman; Rose Bamfo; Julia Sherman; Reisa A Sperling; Dorene M Rentz
Journal:  Clin Neuropsychol       Date:  2014-05-12       Impact factor: 3.535

Review 9.  Early detection of memory impairment in Alzheimer's disease: a neurocognitive perspective on assessment.

Authors:  Georgia Lowndes; Greg Savage
Journal:  Neuropsychol Rev       Date:  2007-09       Impact factor: 7.444

10.  Adaptive cognitive testing in dementia.

Authors:  Hans Wouters; Aeilko H Zwinderman; Willem A van Gool; Ben Schmand; Robert Lindeboom
Journal:  Int J Methods Psychiatr Res       Date:  2009-06       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.